No Data
No Data
BioVie and BioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / July 5, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money
BioVie Initiated at Buy by ThinkEquity
BioVie Initiated at Buy by ThinkEquity
ThinkEquity Initiates Coverage On BioVie With Buy Rating, Announces Price Target of $3
ThinkEquity analyst Ashok Kumar initiates coverage on BioVie (NASDAQ:BIVI) with a Buy rating and announces Price Target of $3.
BioVie Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/01/2024 600.93% ThinkEquity → $3 Initiates Coverage On → Buy 11/30/2023 1068.22% Oppenheimer $12 → $5 M
Express News | BioVie Presents Protocol Design of Upcoming Sunrise-Pd Phase 2 Trial of Bezisterim in Patients With Early Parkinson’s Disease at Atmrd 2024
BioVie and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / June 21, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Mobilicom Ltd. (Nasdaq:MOB) on the RedChip Small Stocks, Big Money show, a sponsore
No Data